Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Sodium, Dietary | 23 | 2024 | 425 | 5.440 |
Why?
|
Fatty Acids, Omega-3 | 39 | 2024 | 1390 | 4.240 |
Why?
|
Cardiovascular Diseases | 120 | 2024 | 15498 | 3.840 |
Why?
|
Cholecalciferol | 24 | 2024 | 553 | 2.410 |
Why?
|
Dietary Supplements | 63 | 2024 | 3412 | 2.320 |
Why?
|
Primary Prevention | 25 | 2020 | 1185 | 2.320 |
Why?
|
Vitamin D | 44 | 2024 | 3301 | 2.170 |
Why?
|
Risk Assessment | 85 | 2024 | 23974 | 2.110 |
Why?
|
Vitamins | 34 | 2024 | 1635 | 2.000 |
Why?
|
Hypertension | 54 | 2024 | 8532 | 1.940 |
Why?
|
Aspirin | 30 | 2018 | 3127 | 1.930 |
Why?
|
Sodium | 15 | 2024 | 1588 | 1.920 |
Why?
|
C-Reactive Protein | 40 | 2022 | 3820 | 1.860 |
Why?
|
ROC Curve | 15 | 2017 | 3575 | 1.570 |
Why?
|
Models, Statistical | 31 | 2019 | 5074 | 1.490 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 14 | 2023 | 3245 | 1.490 |
Why?
|
Blood Pressure | 42 | 2024 | 8473 | 1.410 |
Why?
|
Vitamin E | 18 | 2018 | 872 | 1.280 |
Why?
|
beta Carotene | 17 | 2019 | 523 | 1.230 |
Why?
|
Women's Health | 25 | 2023 | 2066 | 1.160 |
Why?
|
Diet, Sodium-Restricted | 11 | 2020 | 291 | 1.120 |
Why?
|
Stroke | 35 | 2023 | 9715 | 1.040 |
Why?
|
Risk Factors | 168 | 2024 | 74128 | 0.980 |
Why?
|
Sodium Chloride, Dietary | 6 | 2023 | 292 | 0.960 |
Why?
|
Double-Blind Method | 75 | 2024 | 12333 | 0.960 |
Why?
|
Platelet Aggregation Inhibitors | 11 | 2018 | 2746 | 0.960 |
Why?
|
Middle Aged | 282 | 2024 | 220603 | 0.940 |
Why?
|
Lipoproteins | 7 | 2020 | 879 | 0.910 |
Why?
|
Coronary Disease | 20 | 2020 | 5911 | 0.910 |
Why?
|
Randomized Controlled Trials as Topic | 39 | 2024 | 10203 | 0.870 |
Why?
|
Blood Pressure Determination | 11 | 2019 | 633 | 0.860 |
Why?
|
Female | 327 | 2024 | 392203 | 0.840 |
Why?
|
Aged | 205 | 2024 | 169092 | 0.840 |
Why?
|
Mortality | 11 | 2018 | 2899 | 0.830 |
Why?
|
Humans | 432 | 2024 | 760740 | 0.820 |
Why?
|
Death, Sudden, Cardiac | 15 | 2024 | 1551 | 0.800 |
Why?
|
Myocardial Infarction | 26 | 2024 | 11458 | 0.790 |
Why?
|
Postmenopause | 18 | 2018 | 2511 | 0.770 |
Why?
|
Natriuretic Peptide, Brain | 8 | 2020 | 1723 | 0.750 |
Why?
|
Risk Reduction Behavior | 8 | 2020 | 1110 | 0.740 |
Why?
|
Antioxidants | 15 | 2015 | 1669 | 0.730 |
Why?
|
Vitamin B 6 | 11 | 2018 | 234 | 0.710 |
Why?
|
Predictive Value of Tests | 32 | 2024 | 15250 | 0.710 |
Why?
|
Life Style | 19 | 2022 | 3907 | 0.680 |
Why?
|
Incidence | 73 | 2024 | 21339 | 0.680 |
Why?
|
Neoplasms | 34 | 2023 | 22131 | 0.660 |
Why?
|
Proportional Hazards Models | 50 | 2024 | 12448 | 0.650 |
Why?
|
Diet | 17 | 2024 | 8049 | 0.640 |
Why?
|
Risk | 40 | 2016 | 9603 | 0.630 |
Why?
|
Cacao | 3 | 2024 | 98 | 0.610 |
Why?
|
Data Interpretation, Statistical | 10 | 2016 | 2689 | 0.610 |
Why?
|
Fatty Acids, Omega-6 | 1 | 2019 | 225 | 0.610 |
Why?
|
Vitamin B 12 | 11 | 2018 | 524 | 0.590 |
Why?
|
Biometry | 3 | 2017 | 561 | 0.590 |
Why?
|
Sodium Chloride | 2 | 2019 | 586 | 0.590 |
Why?
|
Follow-Up Studies | 77 | 2022 | 39062 | 0.580 |
Why?
|
Prospective Studies | 106 | 2024 | 54364 | 0.570 |
Why?
|
Cholesterol, LDL | 11 | 2022 | 2378 | 0.570 |
Why?
|
Male | 196 | 2024 | 360402 | 0.570 |
Why?
|
Potassium | 4 | 2022 | 1311 | 0.570 |
Why?
|
Decision Support Techniques | 6 | 2024 | 1999 | 0.560 |
Why?
|
Homocysteine | 8 | 2018 | 637 | 0.560 |
Why?
|
Coronary Artery Disease | 9 | 2022 | 6403 | 0.560 |
Why?
|
Urinalysis | 4 | 2024 | 368 | 0.550 |
Why?
|
Diabetes Mellitus, Type 2 | 23 | 2024 | 12143 | 0.550 |
Why?
|
Folic Acid | 12 | 2018 | 1323 | 0.530 |
Why?
|
Vitamin D Deficiency | 8 | 2024 | 1388 | 0.520 |
Why?
|
Cholesterol, HDL | 11 | 2021 | 1810 | 0.500 |
Why?
|
Cholesterol | 6 | 2020 | 2902 | 0.500 |
Why?
|
Hypercholesterolemia | 5 | 2017 | 1141 | 0.490 |
Why?
|
Polymorphism, Genetic | 12 | 2016 | 4242 | 0.490 |
Why?
|
Practice Guidelines as Topic | 7 | 2017 | 7390 | 0.480 |
Why?
|
United States | 83 | 2024 | 72292 | 0.470 |
Why?
|
Atrial Fibrillation | 13 | 2023 | 5031 | 0.470 |
Why?
|
Smoking | 22 | 2019 | 9054 | 0.460 |
Why?
|
Ascorbic Acid | 6 | 2009 | 655 | 0.460 |
Why?
|
Inflammation | 17 | 2024 | 10759 | 0.450 |
Why?
|
Lipoprotein(a) | 2 | 2018 | 479 | 0.450 |
Why?
|
Fatty Acids | 3 | 2023 | 1808 | 0.440 |
Why?
|
Models, Biological | 7 | 2013 | 9461 | 0.430 |
Why?
|
Peak Expiratory Flow Rate | 4 | 1995 | 144 | 0.420 |
Why?
|
Cause of Death | 5 | 2019 | 3683 | 0.410 |
Why?
|
Public Health | 4 | 2023 | 2671 | 0.410 |
Why?
|
Eicosapentaenoic Acid | 6 | 2024 | 561 | 0.410 |
Why?
|
Docosahexaenoic Acids | 5 | 2024 | 907 | 0.400 |
Why?
|
Phospholipases A2 | 1 | 2012 | 197 | 0.400 |
Why?
|
Body Mass Index | 34 | 2021 | 12942 | 0.400 |
Why?
|
Pharmaceutical Preparations | 1 | 2020 | 1086 | 0.400 |
Why?
|
Epidemiologic Methods | 3 | 2011 | 1335 | 0.400 |
Why?
|
Polymorphism, Single Nucleotide | 23 | 2018 | 15908 | 0.390 |
Why?
|
Diabetes Complications | 4 | 2017 | 1315 | 0.390 |
Why?
|
Models, Theoretical | 2 | 2015 | 3567 | 0.390 |
Why?
|
Research Design | 9 | 2020 | 6174 | 0.390 |
Why?
|
Fish Oils | 5 | 2023 | 483 | 0.380 |
Why?
|
Case-Control Studies | 36 | 2024 | 22153 | 0.380 |
Why?
|
Meta-Analysis as Topic | 2 | 2014 | 1380 | 0.380 |
Why?
|
Macular Degeneration | 4 | 2021 | 1008 | 0.370 |
Why?
|
Peptide Fragments | 7 | 2020 | 5109 | 0.370 |
Why?
|
Motor Activity | 8 | 2015 | 2714 | 0.370 |
Why?
|
Migraine Disorders | 9 | 2023 | 1701 | 0.370 |
Why?
|
Nutrition Policy | 2 | 2020 | 466 | 0.360 |
Why?
|
Weight Loss | 7 | 2018 | 2682 | 0.360 |
Why?
|
Calibration | 5 | 2019 | 817 | 0.360 |
Why?
|
Fishes | 3 | 2024 | 602 | 0.350 |
Why?
|
Logistic Models | 19 | 2017 | 13248 | 0.350 |
Why?
|
Adult | 98 | 2024 | 220995 | 0.350 |
Why?
|
Models, Cardiovascular | 2 | 2007 | 981 | 0.350 |
Why?
|
Gastrointestinal Hemorrhage | 2 | 2014 | 1116 | 0.350 |
Why?
|
Cognition Disorders | 13 | 2013 | 3979 | 0.340 |
Why?
|
Area Under Curve | 7 | 2017 | 1635 | 0.340 |
Why?
|
Algorithms | 8 | 2024 | 14024 | 0.340 |
Why?
|
Fluorobenzenes | 1 | 2011 | 179 | 0.340 |
Why?
|
Cohort Studies | 56 | 2023 | 41464 | 0.340 |
Why?
|
Elasticity | 1 | 2011 | 655 | 0.340 |
Why?
|
Time Factors | 32 | 2024 | 39908 | 0.330 |
Why?
|
Evidence-Based Medicine | 3 | 2020 | 3680 | 0.320 |
Why?
|
Age Factors | 32 | 2021 | 18381 | 0.320 |
Why?
|
Exercise | 20 | 2022 | 5886 | 0.320 |
Why?
|
Colorectal Neoplasms | 16 | 2019 | 6927 | 0.320 |
Why?
|
Potassium, Dietary | 1 | 2009 | 103 | 0.310 |
Why?
|
Prognosis | 31 | 2024 | 29601 | 0.310 |
Why?
|
Sex Factors | 23 | 2024 | 10549 | 0.310 |
Why?
|
Depression | 10 | 2023 | 8132 | 0.300 |
Why?
|
Multivariate Analysis | 22 | 2017 | 12043 | 0.300 |
Why?
|
Hyperinsulinism | 3 | 2006 | 400 | 0.300 |
Why?
|
Reproducibility of Results | 15 | 2024 | 20077 | 0.290 |
Why?
|
Urinary Incontinence | 2 | 2022 | 489 | 0.290 |
Why?
|
Triglycerides | 5 | 2020 | 2459 | 0.290 |
Why?
|
Peroxidase | 1 | 2010 | 610 | 0.290 |
Why?
|
Cognition | 14 | 2024 | 6988 | 0.290 |
Why?
|
Regression Analysis | 14 | 2015 | 6339 | 0.280 |
Why?
|
Survival Analysis | 6 | 2019 | 10072 | 0.280 |
Why?
|
Physical Fitness | 5 | 2013 | 743 | 0.280 |
Why?
|
Diagnosis | 1 | 2007 | 156 | 0.270 |
Why?
|
Arteries | 1 | 2011 | 1120 | 0.270 |
Why?
|
Insulin Resistance | 6 | 2024 | 3954 | 0.270 |
Why?
|
Body Height | 8 | 2018 | 1565 | 0.270 |
Why?
|
Alcohol Drinking | 14 | 2020 | 4028 | 0.270 |
Why?
|
Seafood | 2 | 2024 | 393 | 0.270 |
Why?
|
Clinical Medicine | 1 | 2007 | 145 | 0.260 |
Why?
|
Breast Neoplasms | 17 | 2023 | 20988 | 0.260 |
Why?
|
Probability | 8 | 2011 | 2475 | 0.260 |
Why?
|
Troponin T | 3 | 2017 | 780 | 0.260 |
Why?
|
Fractures, Bone | 4 | 2024 | 2045 | 0.250 |
Why?
|
Clinical Trials as Topic | 6 | 2022 | 7995 | 0.250 |
Why?
|
Self Report | 4 | 2024 | 3727 | 0.240 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 5 | 2015 | 2270 | 0.240 |
Why?
|
Brain Ischemia | 8 | 2020 | 3030 | 0.240 |
Why?
|
Coronary Stenosis | 1 | 2010 | 794 | 0.240 |
Why?
|
Cyclooxygenase Inhibitors | 2 | 2005 | 361 | 0.230 |
Why?
|
Drug Administration Schedule | 5 | 2014 | 4845 | 0.230 |
Why?
|
Arthritis, Rheumatoid | 6 | 2023 | 3752 | 0.220 |
Why?
|
Neoplasms, Squamous Cell | 1 | 2004 | 95 | 0.220 |
Why?
|
Accidental Falls | 2 | 2023 | 1067 | 0.220 |
Why?
|
Overweight | 6 | 2023 | 2417 | 0.220 |
Why?
|
Alcohol Dehydrogenase | 1 | 2004 | 111 | 0.220 |
Why?
|
alpha-Tocopherol | 2 | 2019 | 126 | 0.220 |
Why?
|
Glomerular Filtration Rate | 4 | 2024 | 2174 | 0.220 |
Why?
|
Affect | 2 | 2021 | 1486 | 0.210 |
Why?
|
Parathyroid Hormone | 3 | 2024 | 1803 | 0.210 |
Why?
|
Receptors, Estrogen | 3 | 2010 | 2208 | 0.210 |
Why?
|
Preventive Health Services | 2 | 2020 | 566 | 0.210 |
Why?
|
Atherosclerosis | 5 | 2012 | 3400 | 0.210 |
Why?
|
Linear Models | 13 | 2018 | 5866 | 0.210 |
Why?
|
Thromboembolism | 3 | 2006 | 991 | 0.210 |
Why?
|
Mass Screening | 7 | 2017 | 5425 | 0.210 |
Why?
|
C-Peptide | 1 | 2024 | 440 | 0.210 |
Why?
|
Intercellular Adhesion Molecule-1 | 7 | 2011 | 1128 | 0.210 |
Why?
|
Obesity | 19 | 2023 | 12934 | 0.210 |
Why?
|
Magnesium | 4 | 2006 | 804 | 0.200 |
Why?
|
Renin | 1 | 2024 | 640 | 0.200 |
Why?
|
Receptors, Tumor Necrosis Factor, Type II | 4 | 2019 | 344 | 0.200 |
Why?
|
Receptors, Adrenergic, beta-2 | 3 | 2011 | 217 | 0.200 |
Why?
|
Amino Acids, Branched-Chain | 2 | 2022 | 269 | 0.200 |
Why?
|
Longitudinal Studies | 13 | 2019 | 14599 | 0.200 |
Why?
|
Vitamin B Complex | 3 | 2008 | 299 | 0.200 |
Why?
|
Epistasis, Genetic | 1 | 2004 | 350 | 0.200 |
Why?
|
Odds Ratio | 14 | 2018 | 9644 | 0.200 |
Why?
|
Sulfonamides | 1 | 2011 | 1977 | 0.190 |
Why?
|
Ventricular Function, Left | 5 | 2022 | 3873 | 0.190 |
Why?
|
Diet, Mediterranean | 2 | 2022 | 738 | 0.190 |
Why?
|
Statistics, Nonparametric | 3 | 2017 | 2851 | 0.190 |
Why?
|
Aged, 80 and over | 42 | 2021 | 58919 | 0.190 |
Why?
|
Reference Values | 10 | 2020 | 4919 | 0.190 |
Why?
|
Health Status | 9 | 2019 | 4076 | 0.190 |
Why?
|
Lipid Metabolism | 3 | 2021 | 1896 | 0.180 |
Why?
|
Gonadal Steroid Hormones | 3 | 2012 | 702 | 0.180 |
Why?
|
Urinary Bladder, Overactive | 1 | 2022 | 114 | 0.180 |
Why?
|
Lipids | 5 | 2018 | 3332 | 0.180 |
Why?
|
Cerebrovascular Disorders | 3 | 2017 | 1474 | 0.180 |
Why?
|
Autoimmune Diseases | 2 | 2024 | 2238 | 0.180 |
Why?
|
Genetic Variation | 5 | 2014 | 6561 | 0.180 |
Why?
|
Estrogen Replacement Therapy | 8 | 2011 | 1208 | 0.180 |
Why?
|
Fasting | 4 | 2020 | 1603 | 0.180 |
Why?
|
Knee Joint | 2 | 2020 | 1676 | 0.180 |
Why?
|
Medication Adherence | 1 | 2012 | 2175 | 0.180 |
Why?
|
Adiponectin | 3 | 2012 | 1107 | 0.180 |
Why?
|
Computer Simulation | 6 | 2017 | 6233 | 0.170 |
Why?
|
Body Composition | 2 | 2021 | 2426 | 0.170 |
Why?
|
1-Alkyl-2-acetylglycerophosphocholine Esterase | 2 | 2011 | 127 | 0.170 |
Why?
|
Renin-Angiotensin System | 1 | 2024 | 737 | 0.170 |
Why?
|
Creatinine | 3 | 2015 | 1895 | 0.170 |
Why?
|
Connective Tissue Diseases | 4 | 2010 | 285 | 0.170 |
Why?
|
Body Weight | 6 | 2018 | 4615 | 0.170 |
Why?
|
Nutritional Physiological Phenomena | 3 | 2020 | 361 | 0.170 |
Why?
|
Blood Sedimentation | 1 | 2020 | 235 | 0.170 |
Why?
|
Self Medication | 1 | 2000 | 117 | 0.170 |
Why?
|
Insulin | 5 | 2024 | 6593 | 0.170 |
Why?
|
Apolipoprotein E4 | 1 | 2024 | 709 | 0.160 |
Why?
|
Blood Glucose | 5 | 2024 | 6390 | 0.160 |
Why?
|
Pyrimidines | 1 | 2011 | 3027 | 0.160 |
Why?
|
Peripheral Arterial Disease | 3 | 2018 | 1271 | 0.160 |
Why?
|
Treatment Outcome | 23 | 2024 | 64572 | 0.160 |
Why?
|
Mammography | 2 | 2009 | 2430 | 0.160 |
Why?
|
Breast Implants | 4 | 2010 | 407 | 0.160 |
Why?
|
Stroke Volume | 5 | 2024 | 5486 | 0.160 |
Why?
|
Electrocardiography | 6 | 2024 | 6346 | 0.160 |
Why?
|
Interleukin-6 | 6 | 2019 | 3205 | 0.160 |
Why?
|
Depressive Disorder | 3 | 2021 | 3735 | 0.160 |
Why?
|
Nutritional Requirements | 1 | 2020 | 274 | 0.160 |
Why?
|
Aging | 9 | 2021 | 8700 | 0.160 |
Why?
|
Carcinoma, Basal Cell | 1 | 2004 | 557 | 0.160 |
Why?
|
Carcinoma, Large Cell | 1 | 2019 | 113 | 0.160 |
Why?
|
Pain Measurement | 3 | 2020 | 3546 | 0.150 |
Why?
|
Heart Injuries | 1 | 2020 | 203 | 0.150 |
Why?
|
Myocardium | 3 | 2020 | 4725 | 0.150 |
Why?
|
Anticoagulants | 2 | 2012 | 4785 | 0.150 |
Why?
|
Taiwan | 1 | 2019 | 521 | 0.150 |
Why?
|
Endothelium, Vascular | 4 | 2018 | 4433 | 0.150 |
Why?
|
Forecasting | 3 | 2017 | 2924 | 0.150 |
Why?
|
Postprandial Period | 2 | 2020 | 314 | 0.150 |
Why?
|
Adiposity | 5 | 2021 | 1879 | 0.140 |
Why?
|
Diet Surveys | 2 | 2020 | 1161 | 0.140 |
Why?
|
Dry Eye Syndromes | 1 | 2022 | 388 | 0.140 |
Why?
|
Bone Density | 4 | 2021 | 3548 | 0.140 |
Why?
|
Dose-Response Relationship, Drug | 11 | 2021 | 10754 | 0.140 |
Why?
|
Chromosomes, Human, Pair 9 | 2 | 2009 | 535 | 0.140 |
Why?
|
Statistics as Topic | 3 | 2016 | 2358 | 0.140 |
Why?
|
Sex Hormone-Binding Globulin | 4 | 2012 | 550 | 0.140 |
Why?
|
Catechol O-Methyltransferase | 1 | 2019 | 251 | 0.140 |
Why?
|
Sex Characteristics | 6 | 2022 | 2637 | 0.140 |
Why?
|
Comorbidity | 11 | 2020 | 10507 | 0.140 |
Why?
|
Health Status Indicators | 2 | 2014 | 970 | 0.140 |
Why?
|
Nutrition Surveys | 2 | 2017 | 1725 | 0.140 |
Why?
|
Vitamin D-Binding Protein | 1 | 2018 | 131 | 0.140 |
Why?
|
Policy Making | 1 | 2020 | 541 | 0.140 |
Why?
|
Genetic Predisposition to Disease | 11 | 2018 | 17878 | 0.140 |
Why?
|
Neoplasm Metastasis | 2 | 2020 | 4910 | 0.140 |
Why?
|
Oxidoreductases Acting on CH-CH Group Donors | 1 | 2018 | 174 | 0.130 |
Why?
|
Diabetes Mellitus | 6 | 2021 | 5838 | 0.130 |
Why?
|
Metformin | 2 | 2017 | 906 | 0.130 |
Why?
|
Placebo Effect | 1 | 2020 | 518 | 0.130 |
Why?
|
Phosphatidylcholines | 1 | 2018 | 405 | 0.130 |
Why?
|
Pharmacogenetics | 1 | 2020 | 675 | 0.130 |
Why?
|
Leukoencephalopathies | 1 | 2019 | 256 | 0.130 |
Why?
|
Genetic Association Studies | 2 | 2019 | 2734 | 0.130 |
Why?
|
Troponin I | 1 | 2020 | 650 | 0.130 |
Why?
|
American Heart Association | 3 | 2016 | 1039 | 0.130 |
Why?
|
Calcium | 3 | 2023 | 5717 | 0.130 |
Why?
|
Amino Acid Substitution | 3 | 2005 | 1739 | 0.130 |
Why?
|
Depressive Disorder, Major | 2 | 2023 | 4764 | 0.120 |
Why?
|
Treatment Failure | 5 | 2021 | 2635 | 0.120 |
Why?
|
Adaptor Proteins, Vesicular Transport | 1 | 2017 | 304 | 0.120 |
Why?
|
Feeding Behavior | 4 | 2020 | 3183 | 0.120 |
Why?
|
Survival Rate | 10 | 2019 | 12719 | 0.120 |
Why?
|
Cross-Sectional Studies | 17 | 2023 | 26065 | 0.120 |
Why?
|
Glycemic Index | 3 | 2008 | 396 | 0.120 |
Why?
|
DNA, Mitochondrial | 1 | 2020 | 865 | 0.120 |
Why?
|
Defibrillators, Implantable | 1 | 2024 | 1483 | 0.120 |
Why?
|
Eating | 2 | 2019 | 1535 | 0.120 |
Why?
|
Confidence Intervals | 7 | 2013 | 2925 | 0.120 |
Why?
|
Genotype | 16 | 2024 | 12977 | 0.120 |
Why?
|
Models, Genetic | 2 | 2004 | 3431 | 0.120 |
Why?
|
Telomere | 1 | 2021 | 942 | 0.120 |
Why?
|
Diabetic Nephropathies | 1 | 2022 | 972 | 0.120 |
Why?
|
Resistance Training | 1 | 2017 | 193 | 0.120 |
Why?
|
Aorta, Abdominal | 1 | 2017 | 625 | 0.110 |
Why?
|
Chemokines, CC | 2 | 2005 | 283 | 0.110 |
Why?
|
Systole | 4 | 2018 | 935 | 0.110 |
Why?
|
Myocardial Revascularization | 4 | 2020 | 790 | 0.110 |
Why?
|
Heart Failure | 4 | 2022 | 11670 | 0.110 |
Why?
|
Seasons | 2 | 2019 | 1518 | 0.110 |
Why?
|
Arthralgia | 1 | 2018 | 461 | 0.110 |
Why?
|
Drug Therapy, Combination | 8 | 2021 | 6305 | 0.110 |
Why?
|
Contraceptives, Oral | 2 | 2007 | 553 | 0.110 |
Why?
|
Directive Counseling | 2 | 2005 | 170 | 0.110 |
Why?
|
Alanine Transaminase | 1 | 2016 | 601 | 0.110 |
Why?
|
Tropicamide | 1 | 2012 | 22 | 0.110 |
Why?
|
Mydriatics | 1 | 2012 | 67 | 0.100 |
Why?
|
Hypertension, Pregnancy-Induced | 1 | 2018 | 517 | 0.100 |
Why?
|
Severity of Illness Index | 7 | 2019 | 15829 | 0.100 |
Why?
|
Gene Frequency | 6 | 2018 | 3601 | 0.100 |
Why?
|
Hormone Replacement Therapy | 3 | 2009 | 751 | 0.100 |
Why?
|
P-Selectin | 2 | 2005 | 599 | 0.100 |
Why?
|
Patient Admission | 1 | 2019 | 1365 | 0.100 |
Why?
|
Hypertriglyceridemia | 1 | 2015 | 293 | 0.100 |
Why?
|
Phenylephrine | 1 | 2012 | 293 | 0.100 |
Why?
|
Lung Neoplasms | 6 | 2019 | 13383 | 0.100 |
Why?
|
Antihypertensive Agents | 5 | 2013 | 2018 | 0.100 |
Why?
|
Cardiology | 1 | 2023 | 1656 | 0.100 |
Why?
|
Aromatase | 1 | 2012 | 147 | 0.100 |
Why?
|
Parity | 2 | 2018 | 924 | 0.100 |
Why?
|
Health Surveys | 9 | 2020 | 4036 | 0.100 |
Why?
|
Clinical Trials, Phase I as Topic | 1 | 1993 | 326 | 0.100 |
Why?
|
Epidemiologic Studies | 5 | 2013 | 673 | 0.100 |
Why?
|
Sample Size | 1 | 2015 | 838 | 0.100 |
Why?
|
DNA Copy Number Variations | 1 | 2020 | 2020 | 0.100 |
Why?
|
Absorptiometry, Photon | 4 | 2020 | 1738 | 0.090 |
Why?
|
Hyperglycemia | 1 | 2020 | 1375 | 0.090 |
Why?
|
Osteoarthritis, Knee | 2 | 2020 | 1234 | 0.090 |
Why?
|
Dietary Fats | 2 | 2012 | 1995 | 0.090 |
Why?
|
Aortic Diseases | 1 | 2017 | 735 | 0.090 |
Why?
|
Hepatocyte Growth Factor | 1 | 2012 | 271 | 0.090 |
Why?
|
Anticarcinogenic Agents | 1 | 2012 | 249 | 0.090 |
Why?
|
Leisure Activities | 1 | 2012 | 308 | 0.090 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 2 | 2019 | 5319 | 0.090 |
Why?
|
Validation Studies as Topic | 1 | 2010 | 162 | 0.090 |
Why?
|
Estradiol Dehydrogenases | 1 | 2010 | 16 | 0.090 |
Why?
|
Drug Combinations | 5 | 2018 | 2048 | 0.090 |
Why?
|
Receptors, Progesterone | 3 | 2010 | 1129 | 0.090 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 3 | 2010 | 691 | 0.090 |
Why?
|
Death | 1 | 2014 | 674 | 0.090 |
Why?
|
KCNQ1 Potassium Channel | 1 | 2010 | 102 | 0.090 |
Why?
|
Chi-Square Distribution | 6 | 2017 | 3410 | 0.090 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2022 | 2152 | 0.080 |
Why?
|
Forced Expiratory Flow Rates | 1 | 1989 | 75 | 0.080 |
Why?
|
Kidney Diseases | 2 | 2011 | 2090 | 0.080 |
Why?
|
Haplotypes | 4 | 2010 | 2713 | 0.080 |
Why?
|
Fibrinogen | 2 | 2010 | 887 | 0.080 |
Why?
|
Health Behavior | 2 | 2012 | 2643 | 0.080 |
Why?
|
Potassium Channels, Voltage-Gated | 1 | 2010 | 141 | 0.080 |
Why?
|
Fruit | 2 | 2005 | 1158 | 0.080 |
Why?
|
Inflammation Mediators | 1 | 2018 | 1884 | 0.080 |
Why?
|
Vegetables | 2 | 2005 | 1192 | 0.080 |
Why?
|
Receptors, Steroid | 1 | 2010 | 156 | 0.080 |
Why?
|
Hypoglycemic Agents | 3 | 2017 | 3085 | 0.080 |
Why?
|
Receptors, Interleukin-4 | 2 | 2006 | 64 | 0.080 |
Why?
|
Evoked Potentials, Auditory | 1 | 2012 | 530 | 0.080 |
Why?
|
Life Expectancy | 1 | 2016 | 1242 | 0.080 |
Why?
|
Genome, Human | 4 | 2010 | 4421 | 0.080 |
Why?
|
Antineoplastic Agents | 1 | 2012 | 13635 | 0.080 |
Why?
|
Chemokine CCL11 | 2 | 2005 | 128 | 0.080 |
Why?
|
Lymphotoxin-alpha | 1 | 2009 | 93 | 0.080 |
Why?
|
Environmental Monitoring | 1 | 2015 | 1460 | 0.080 |
Why?
|
Heart Diseases | 2 | 2017 | 2778 | 0.080 |
Why?
|
Metabolomics | 1 | 2018 | 1656 | 0.080 |
Why?
|
Sudden Infant Death | 1 | 2011 | 292 | 0.080 |
Why?
|
Sodium Channels | 1 | 2010 | 339 | 0.080 |
Why?
|
Age Distribution | 3 | 2016 | 2872 | 0.080 |
Why?
|
Heart Rate | 1 | 2020 | 4181 | 0.080 |
Why?
|
Physicians | 8 | 2006 | 4583 | 0.070 |
Why?
|
Sex Distribution | 3 | 2008 | 2278 | 0.070 |
Why?
|
Monitoring, Physiologic | 1 | 2015 | 1780 | 0.070 |
Why?
|
Neoplasm Staging | 2 | 2019 | 11118 | 0.070 |
Why?
|
Retinopathy of Prematurity | 1 | 2012 | 439 | 0.070 |
Why?
|
Estrogens, Conjugated (USP) | 2 | 2006 | 276 | 0.070 |
Why?
|
Muscles | 2 | 2023 | 1573 | 0.070 |
Why?
|
Diet Records | 2 | 2019 | 427 | 0.070 |
Why?
|
Bone Density Conservation Agents | 1 | 2015 | 794 | 0.070 |
Why?
|
Causality | 2 | 2011 | 1241 | 0.070 |
Why?
|
Analysis of Variance | 4 | 2010 | 6223 | 0.070 |
Why?
|
Arthroplasty, Replacement, Knee | 1 | 2018 | 1393 | 0.070 |
Why?
|
Activities of Daily Living | 5 | 2023 | 2419 | 0.070 |
Why?
|
Bayes Theorem | 2 | 2014 | 2327 | 0.070 |
Why?
|
Carotenoids | 5 | 1996 | 621 | 0.070 |
Why?
|
Disease-Free Survival | 4 | 2019 | 6807 | 0.070 |
Why?
|
Netherlands | 3 | 2020 | 2222 | 0.070 |
Why?
|
Stochastic Processes | 1 | 2007 | 355 | 0.070 |
Why?
|
Healthcare Disparities | 2 | 2021 | 3351 | 0.070 |
Why?
|
Respiration Disorders | 1 | 1989 | 367 | 0.070 |
Why?
|
Nootropic Agents | 1 | 2007 | 157 | 0.070 |
Why?
|
Selenoprotein P | 1 | 2005 | 33 | 0.070 |
Why?
|
SAIDS Vaccines | 2 | 1998 | 144 | 0.060 |
Why?
|
Alleles | 7 | 2019 | 6861 | 0.060 |
Why?
|
Neuropsychological Tests | 5 | 2024 | 7050 | 0.060 |
Why?
|
Environmental Pollutants | 1 | 2015 | 1277 | 0.060 |
Why?
|
Lipoprotein Lipase | 1 | 2006 | 133 | 0.060 |
Why?
|
Venous Thrombosis | 2 | 2006 | 1303 | 0.060 |
Why?
|
Diastole | 2 | 2000 | 781 | 0.060 |
Why?
|
Migraine without Aura | 1 | 2006 | 82 | 0.060 |
Why?
|
Reproductive History | 1 | 2007 | 210 | 0.060 |
Why?
|
Skin Neoplasms | 2 | 2004 | 5811 | 0.060 |
Why?
|
Patient Compliance | 6 | 2016 | 2688 | 0.060 |
Why?
|
Likelihood Functions | 1 | 2008 | 991 | 0.060 |
Why?
|
Normal Distribution | 1 | 2006 | 272 | 0.060 |
Why?
|
Saliva | 2 | 1988 | 828 | 0.060 |
Why?
|
Drug Prescriptions | 1 | 2014 | 1669 | 0.060 |
Why?
|
Prevalence | 9 | 2023 | 15702 | 0.060 |
Why?
|
Cysteine | 1 | 2010 | 891 | 0.060 |
Why?
|
Cost Savings | 1 | 2010 | 912 | 0.060 |
Why?
|
Patient Selection | 3 | 2016 | 4237 | 0.060 |
Why?
|
Peripheral Vascular Diseases | 1 | 2008 | 488 | 0.060 |
Why?
|
Arteriosclerosis | 1 | 2009 | 1056 | 0.060 |
Why?
|
Coronary Angiography | 1 | 2016 | 4470 | 0.060 |
Why?
|
Angioplasty, Balloon, Coronary | 3 | 2011 | 1723 | 0.060 |
Why?
|
Energy Intake | 6 | 2010 | 2133 | 0.060 |
Why?
|
Muscle Proteins | 1 | 2010 | 1152 | 0.060 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2019 | 2252 | 0.060 |
Why?
|
gamma-Linolenic Acid | 1 | 2004 | 16 | 0.060 |
Why?
|
Tocopherols | 1 | 2004 | 44 | 0.060 |
Why?
|
Anthropometry | 4 | 2008 | 1338 | 0.060 |
Why?
|
Waist-Hip Ratio | 1 | 2006 | 518 | 0.060 |
Why?
|
Occupations | 2 | 2005 | 516 | 0.060 |
Why?
|
Hydroxymethylglutaryl CoA Reductases | 1 | 2004 | 60 | 0.060 |
Why?
|
Migraine with Aura | 1 | 2006 | 204 | 0.060 |
Why?
|
Molecular Weight | 2 | 2020 | 2185 | 0.060 |
Why?
|
Apolipoprotein A-I | 2 | 2020 | 299 | 0.060 |
Why?
|
Kaplan-Meier Estimate | 4 | 2018 | 6473 | 0.060 |
Why?
|
Testosterone | 4 | 2012 | 2472 | 0.060 |
Why?
|
Child Welfare | 1 | 2008 | 521 | 0.060 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2019 | 4021 | 0.050 |
Why?
|
Thrombophilia | 1 | 2006 | 306 | 0.050 |
Why?
|
Yohimbine | 1 | 1983 | 62 | 0.050 |
Why?
|
Prazosin | 1 | 1983 | 95 | 0.050 |
Why?
|
Walking | 4 | 2018 | 1197 | 0.050 |
Why?
|
Oxidative Stress | 4 | 2009 | 3115 | 0.050 |
Why?
|
Receptors, Adrenergic, alpha | 1 | 1983 | 146 | 0.050 |
Why?
|
Receptors, Adrenergic | 1 | 1983 | 155 | 0.050 |
Why?
|
Neuroprotective Agents | 1 | 2009 | 957 | 0.050 |
Why?
|
Minerals | 1 | 2024 | 283 | 0.050 |
Why?
|
Dexamethasone | 2 | 1988 | 1946 | 0.050 |
Why?
|
Pravastatin | 1 | 2004 | 392 | 0.050 |
Why?
|
Calcium, Dietary | 1 | 2005 | 529 | 0.050 |
Why?
|
Birth Weight | 1 | 2010 | 2101 | 0.050 |
Why?
|
Research Support as Topic | 1 | 2006 | 697 | 0.050 |
Why?
|
Calcifediol | 1 | 2023 | 161 | 0.050 |
Why?
|
Quantitative Trait Loci | 1 | 2010 | 2112 | 0.050 |
Why?
|
Adenoma | 1 | 2012 | 2159 | 0.050 |
Why?
|
Europe | 2 | 2024 | 3415 | 0.050 |
Why?
|
Adolescent | 19 | 2013 | 88247 | 0.050 |
Why?
|
Hydrocortisone | 2 | 1988 | 1819 | 0.050 |
Why?
|
Editorial Policies | 1 | 2006 | 458 | 0.050 |
Why?
|
Headache | 1 | 1989 | 1255 | 0.050 |
Why?
|
Food Industry | 1 | 2022 | 67 | 0.050 |
Why?
|
Cost-Benefit Analysis | 4 | 2019 | 5493 | 0.050 |
Why?
|
Genes, p53 | 1 | 2004 | 712 | 0.050 |
Why?
|
Arrhythmias, Cardiac | 2 | 2009 | 2234 | 0.050 |
Why?
|
Conflict of Interest | 1 | 2006 | 554 | 0.050 |
Why?
|
Dietary Fiber | 1 | 2005 | 758 | 0.050 |
Why?
|
Vitamin A | 1 | 2004 | 612 | 0.050 |
Why?
|
Coronary Restenosis | 1 | 2004 | 396 | 0.050 |
Why?
|
Quantitative Trait, Heritable | 1 | 2004 | 540 | 0.050 |
Why?
|
Common Cold | 1 | 2001 | 63 | 0.050 |
Why?
|
Hypoplastic Left Heart Syndrome | 2 | 1997 | 594 | 0.050 |
Why?
|
Cell Adhesion Molecules | 1 | 2007 | 1602 | 0.050 |
Why?
|
Neoplasm Invasiveness | 2 | 2007 | 3593 | 0.050 |
Why?
|
Placebos | 4 | 2009 | 1667 | 0.040 |
Why?
|
Simian immunodeficiency virus | 3 | 1998 | 810 | 0.040 |
Why?
|
Child | 17 | 2013 | 80089 | 0.040 |
Why?
|
Silicones | 1 | 2001 | 228 | 0.040 |
Why?
|
Anti-Inflammatory Agents | 1 | 2010 | 1810 | 0.040 |
Why?
|
Positron-Emission Tomography | 1 | 2016 | 6483 | 0.040 |
Why?
|
Prostatic Neoplasms | 2 | 2000 | 11107 | 0.040 |
Why?
|
Estradiol | 4 | 2012 | 1937 | 0.040 |
Why?
|
Interleukin-4 | 1 | 2003 | 1146 | 0.040 |
Why?
|
Socioeconomic Factors | 3 | 2019 | 7805 | 0.040 |
Why?
|
Antibodies, Antinuclear | 1 | 2001 | 342 | 0.040 |
Why?
|
Hemorrhage | 1 | 2011 | 3418 | 0.040 |
Why?
|
Endometrial Neoplasms | 1 | 2009 | 1365 | 0.040 |
Why?
|
Brain-Derived Neurotrophic Factor | 1 | 2023 | 602 | 0.040 |
Why?
|
Plant Extracts | 1 | 2023 | 497 | 0.040 |
Why?
|
Genetic Loci | 1 | 2008 | 2624 | 0.040 |
Why?
|
Glucose | 2 | 2008 | 4345 | 0.040 |
Why?
|
Recurrence | 3 | 2020 | 8426 | 0.040 |
Why?
|
Diagnostic Imaging | 1 | 2013 | 3527 | 0.040 |
Why?
|
Diagnostic Self Evaluation | 1 | 2020 | 225 | 0.040 |
Why?
|
Vascular Diseases | 1 | 2007 | 1159 | 0.040 |
Why?
|
Apolipoproteins B | 2 | 2011 | 385 | 0.040 |
Why?
|
Boston | 9 | 2005 | 9313 | 0.040 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2003 | 858 | 0.040 |
Why?
|
Intestinal Mucosa | 3 | 1999 | 3031 | 0.040 |
Why?
|
Erythrocytes | 1 | 2007 | 2410 | 0.040 |
Why?
|
International Agencies | 1 | 2019 | 242 | 0.040 |
Why?
|
Apolipoproteins E | 1 | 2024 | 1443 | 0.040 |
Why?
|
Femur Neck | 1 | 2020 | 314 | 0.040 |
Why?
|
Decision Making | 1 | 2012 | 3919 | 0.040 |
Why?
|
Colonic Neoplasms | 2 | 2000 | 2533 | 0.040 |
Why?
|
Animals | 11 | 2024 | 168202 | 0.040 |
Why?
|
Nutritional Status | 2 | 2018 | 1597 | 0.040 |
Why?
|
Lipoproteins, VLDL | 1 | 2018 | 201 | 0.040 |
Why?
|
Ischemia | 1 | 2006 | 1885 | 0.040 |
Why?
|
Immunization | 2 | 1999 | 1217 | 0.040 |
Why?
|
Anticholesteremic Agents | 2 | 2018 | 967 | 0.040 |
Why?
|
Hospitalization | 2 | 2022 | 10708 | 0.040 |
Why?
|
Lymph Nodes | 3 | 1999 | 3461 | 0.040 |
Why?
|
Osteoporosis | 2 | 2022 | 1604 | 0.040 |
Why?
|
Gene Products, gag | 1 | 1998 | 312 | 0.040 |
Why?
|
Biological Availability | 1 | 2018 | 389 | 0.040 |
Why?
|
Pain | 2 | 2023 | 5062 | 0.040 |
Why?
|
Population Surveillance | 3 | 2007 | 2597 | 0.030 |
Why?
|
Brain Mapping | 1 | 2012 | 6635 | 0.030 |
Why?
|
Income | 1 | 2005 | 1870 | 0.030 |
Why?
|
Heart Bypass, Right | 1 | 1997 | 75 | 0.030 |
Why?
|
Ontario | 1 | 2018 | 397 | 0.030 |
Why?
|
DNA | 1 | 2010 | 7196 | 0.030 |
Why?
|
Immunity, Innate | 2 | 2006 | 3045 | 0.030 |
Why?
|
Quality-Adjusted Life Years | 2 | 2016 | 1723 | 0.030 |
Why?
|
Menopause | 4 | 2007 | 1645 | 0.030 |
Why?
|
E-Selectin | 2 | 2010 | 577 | 0.030 |
Why?
|
Visual Acuity | 2 | 2017 | 2676 | 0.030 |
Why?
|
Feasibility Studies | 2 | 2020 | 5239 | 0.030 |
Why?
|
Death, Sudden | 1 | 2018 | 301 | 0.030 |
Why?
|
Quinazolines | 1 | 1983 | 1371 | 0.030 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2007 | 4340 | 0.030 |
Why?
|
Nuclear Magnetic Resonance, Biomolecular | 1 | 2018 | 509 | 0.030 |
Why?
|
Subarachnoid Hemorrhage | 1 | 2003 | 1033 | 0.030 |
Why?
|
Blood Pressure Monitors | 1 | 1995 | 33 | 0.030 |
Why?
|
France | 1 | 2017 | 492 | 0.030 |
Why?
|
Proteins | 1 | 2010 | 6030 | 0.030 |
Why?
|
Cerebral Hemorrhage | 2 | 2005 | 2642 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 2 | 2020 | 36401 | 0.030 |
Why?
|
Weight Gain | 1 | 2006 | 2349 | 0.030 |
Why?
|
Angiotensin II | 1 | 1998 | 849 | 0.030 |
Why?
|
Foundations | 1 | 1995 | 95 | 0.030 |
Why?
|
Child, Preschool | 9 | 2009 | 42193 | 0.030 |
Why?
|
Endpoint Determination | 2 | 2008 | 590 | 0.030 |
Why?
|
Massachusetts | 3 | 2015 | 8835 | 0.030 |
Why?
|
Cytotoxicity, Immunologic | 1 | 1999 | 1349 | 0.030 |
Why?
|
Periodicals as Topic | 1 | 2006 | 1463 | 0.030 |
Why?
|
Genetic Markers | 2 | 2013 | 2601 | 0.030 |
Why?
|
Bipolar Disorder | 1 | 2012 | 5091 | 0.030 |
Why?
|
Tobacco Smoke Pollution | 1 | 2001 | 820 | 0.030 |
Why?
|
Executive Function | 1 | 2023 | 1391 | 0.030 |
Why?
|
Introns | 2 | 2010 | 968 | 0.030 |
Why?
|
Resource Allocation | 1 | 2017 | 350 | 0.030 |
Why?
|
Potassium Chloride | 1 | 1995 | 229 | 0.030 |
Why?
|
Ethanol | 2 | 2005 | 1320 | 0.030 |
Why?
|
Mutation | 1 | 2019 | 30015 | 0.030 |
Why?
|
Demography | 2 | 2009 | 1643 | 0.030 |
Why?
|
Chromatography, Liquid | 1 | 2018 | 982 | 0.030 |
Why?
|
Lipoproteins, HDL | 1 | 2018 | 675 | 0.030 |
Why?
|
Viral Envelope Proteins | 1 | 1998 | 640 | 0.030 |
Why?
|
Hip Fractures | 1 | 2022 | 988 | 0.030 |
Why?
|
Palliative Care | 4 | 1997 | 3593 | 0.030 |
Why?
|
Endocardial Cushion Defects | 1 | 1993 | 43 | 0.030 |
Why?
|
Natriuresis | 1 | 1993 | 105 | 0.030 |
Why?
|
Crohn Disease | 1 | 2006 | 2279 | 0.030 |
Why?
|
Schizophrenia | 1 | 2012 | 6929 | 0.030 |
Why?
|
Genome-Wide Association Study | 2 | 2014 | 12661 | 0.030 |
Why?
|
Disease Progression | 2 | 2020 | 13495 | 0.030 |
Why?
|
Vaccines, Synthetic | 1 | 1996 | 612 | 0.030 |
Why?
|
Homeostasis | 1 | 2024 | 3321 | 0.030 |
Why?
|
HIV Envelope Protein gp120 | 1 | 1998 | 914 | 0.030 |
Why?
|
Pregnancy | 2 | 2018 | 29869 | 0.030 |
Why?
|
Young Adult | 2 | 2017 | 59191 | 0.030 |
Why?
|
Homozygote | 2 | 2011 | 1776 | 0.030 |
Why?
|
Truncus Arteriosus, Persistent | 1 | 1993 | 63 | 0.030 |
Why?
|
Magnetic Resonance Imaging, Cine | 1 | 2020 | 1048 | 0.030 |
Why?
|
Memory | 2 | 2013 | 2192 | 0.030 |
Why?
|
Canada | 1 | 2018 | 2120 | 0.030 |
Why?
|
Sensory Gating | 1 | 2012 | 47 | 0.030 |
Why?
|
Linkage Disequilibrium | 2 | 2010 | 1994 | 0.030 |
Why?
|
Philadelphia | 1 | 2012 | 267 | 0.020 |
Why?
|
Mental Recall | 1 | 2018 | 1222 | 0.020 |
Why?
|
Mendelian Randomization Analysis | 1 | 2018 | 1007 | 0.020 |
Why?
|
Atrial Natriuretic Factor | 1 | 2013 | 350 | 0.020 |
Why?
|
Tandem Mass Spectrometry | 1 | 2018 | 1186 | 0.020 |
Why?
|
Ophthalmic Solutions | 1 | 2012 | 312 | 0.020 |
Why?
|
Premenopause | 2 | 2007 | 1038 | 0.020 |
Why?
|
Poisson Distribution | 1 | 2012 | 504 | 0.020 |
Why?
|
Dehydroepiandrosterone | 1 | 2012 | 258 | 0.020 |
Why?
|
Psychological Tests | 3 | 2007 | 639 | 0.020 |
Why?
|
Retrospective Studies | 10 | 2019 | 80583 | 0.020 |
Why?
|
Memory Disorders | 2 | 2009 | 1197 | 0.020 |
Why?
|
Cytokines | 1 | 2005 | 7373 | 0.020 |
Why?
|
Communication | 2 | 2017 | 3851 | 0.020 |
Why?
|
Health Policy | 1 | 2023 | 2682 | 0.020 |
Why?
|
Eligibility Determination | 1 | 1994 | 421 | 0.020 |
Why?
|
Multicenter Studies as Topic | 1 | 1995 | 1700 | 0.020 |
Why?
|
Physical Endurance | 1 | 2013 | 366 | 0.020 |
Why?
|
Phenotype | 3 | 2018 | 16572 | 0.020 |
Why?
|
Women | 1 | 2012 | 224 | 0.020 |
Why?
|
Lymphoma | 1 | 1999 | 1899 | 0.020 |
Why?
|
Coronary Artery Bypass | 2 | 2011 | 2188 | 0.020 |
Why?
|
Ether-A-Go-Go Potassium Channels | 1 | 2010 | 72 | 0.020 |
Why?
|
Indians, North American | 1 | 2014 | 351 | 0.020 |
Why?
|
Needs Assessment | 1 | 2016 | 1139 | 0.020 |
Why?
|
Cost of Illness | 1 | 2020 | 1937 | 0.020 |
Why?
|
Pyridoxal Phosphate | 1 | 2010 | 121 | 0.020 |
Why?
|
Clinical Protocols | 1 | 2016 | 1436 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 3798 | 0.020 |
Why?
|
Cardiovascular Agents | 1 | 2016 | 840 | 0.020 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2020 | 3769 | 0.020 |
Why?
|
Residence Characteristics | 1 | 2019 | 2092 | 0.020 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 1 | 2011 | 323 | 0.020 |
Why?
|
Ischemic Attack, Transient | 1 | 1995 | 874 | 0.020 |
Why?
|
United Arab Emirates | 1 | 2009 | 42 | 0.020 |
Why?
|
Insulin, Long-Acting | 1 | 2009 | 58 | 0.020 |
Why?
|
Waist Circumference | 1 | 2013 | 933 | 0.020 |
Why?
|
Chemokines | 3 | 1999 | 954 | 0.020 |
Why?
|
Environment | 1 | 1995 | 1123 | 0.020 |
Why?
|
Registries | 2 | 2020 | 8209 | 0.020 |
Why?
|
Muscle Strength | 1 | 2013 | 624 | 0.020 |
Why?
|
Austria | 1 | 2009 | 206 | 0.020 |
Why?
|
Femur | 1 | 2015 | 1307 | 0.020 |
Why?
|
Multifactorial Inheritance | 1 | 2016 | 1381 | 0.020 |
Why?
|
Infant | 9 | 2011 | 36157 | 0.020 |
Why?
|
Hyperhomocysteinemia | 1 | 2008 | 118 | 0.020 |
Why?
|
Health Status Disparities | 1 | 2020 | 1846 | 0.020 |
Why?
|
Rheumatoid Factor | 1 | 2008 | 184 | 0.020 |
Why?
|
Hip Joint | 1 | 2015 | 1014 | 0.020 |
Why?
|
Culture | 1 | 2012 | 623 | 0.020 |
Why?
|
Acoustic Stimulation | 1 | 2012 | 1235 | 0.020 |
Why?
|
Up-Regulation | 1 | 2017 | 4117 | 0.020 |
Why?
|
Beer | 1 | 2008 | 134 | 0.020 |
Why?
|
Body Fat Distribution | 1 | 2009 | 245 | 0.020 |
Why?
|
Suppressor Factors, Immunologic | 2 | 1998 | 68 | 0.020 |
Why?
|
Brain | 2 | 2012 | 27100 | 0.020 |
Why?
|
Adenocarcinoma | 1 | 2005 | 6345 | 0.020 |
Why?
|
Wine | 1 | 2008 | 166 | 0.020 |
Why?
|
Cocarcinogenesis | 1 | 2007 | 49 | 0.020 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2018 | 2118 | 0.020 |
Why?
|
Equipment Design | 1 | 1995 | 3501 | 0.020 |
Why?
|
Markov Chains | 1 | 2010 | 965 | 0.020 |
Why?
|
Membrane Glycoproteins | 1 | 1998 | 3688 | 0.020 |
Why?
|
Infant, Newborn | 5 | 2012 | 26183 | 0.020 |
Why?
|
Health Personnel | 4 | 2005 | 3333 | 0.020 |
Why?
|
Oxygen Consumption | 1 | 2013 | 1866 | 0.020 |
Why?
|
Germany | 1 | 2009 | 872 | 0.020 |
Why?
|
Leukocyte Count | 1 | 2010 | 1597 | 0.020 |
Why?
|
Health Literacy | 1 | 2012 | 443 | 0.020 |
Why?
|
Blood Specimen Collection | 1 | 2007 | 238 | 0.020 |
Why?
|
Carcinoma, Renal Cell | 1 | 2001 | 3164 | 0.020 |
Why?
|
Simian Acquired Immunodeficiency Syndrome | 1 | 1990 | 541 | 0.020 |
Why?
|
Immunoglobulin A | 2 | 2001 | 978 | 0.020 |
Why?
|
Apolipoproteins A | 1 | 2006 | 95 | 0.020 |
Why?
|
Anti-Arrhythmia Agents | 1 | 2010 | 763 | 0.020 |
Why?
|
Cardiac Resynchronization Therapy | 1 | 2012 | 557 | 0.020 |
Why?
|
Angina Pectoris | 1 | 1989 | 959 | 0.020 |
Why?
|
Intensive Care Units, Neonatal | 1 | 2012 | 846 | 0.020 |
Why?
|
Factor V | 1 | 2006 | 167 | 0.020 |
Why?
|
Bereavement | 1 | 1989 | 309 | 0.020 |
Why?
|
Health Services for the Aged | 1 | 1988 | 258 | 0.020 |
Why?
|
Cardiotonic Agents | 1 | 2008 | 539 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2012 | 2703 | 0.020 |
Why?
|
Patient Readmission | 1 | 2019 | 3269 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 1999 | 4570 | 0.020 |
Why?
|
Single-Blind Method | 1 | 2009 | 1575 | 0.020 |
Why?
|
Interleukin-1beta | 1 | 2011 | 998 | 0.020 |
Why?
|
Estrogens | 2 | 2004 | 1521 | 0.020 |
Why?
|
Melanoma | 2 | 1999 | 5696 | 0.020 |
Why?
|
Immunity, Mucosal | 2 | 1999 | 483 | 0.020 |
Why?
|
Dietary Carbohydrates | 1 | 2010 | 891 | 0.020 |
Why?
|
Thymine | 1 | 2005 | 68 | 0.020 |
Why?
|
Rats | 2 | 2016 | 23716 | 0.010 |
Why?
|
Kidney Neoplasms | 1 | 2001 | 4252 | 0.010 |
Why?
|
Plasma | 1 | 2008 | 586 | 0.010 |
Why?
|
Dietary Proteins | 1 | 2010 | 951 | 0.010 |
Why?
|
Macaca mulatta | 3 | 1998 | 2328 | 0.010 |
Why?
|
Central Nervous System Depressants | 1 | 2005 | 164 | 0.010 |
Why?
|
Angiotensins | 1 | 2005 | 142 | 0.010 |
Why?
|
Epidemiologic Research Design | 1 | 2007 | 368 | 0.010 |
Why?
|
Apolipoproteins C | 1 | 2003 | 59 | 0.010 |
Why?
|
Administration, Oral | 2 | 2006 | 4010 | 0.010 |
Why?
|
Menarche | 1 | 2007 | 532 | 0.010 |
Why?
|
Physician-Patient Relations | 1 | 2017 | 3239 | 0.010 |
Why?
|
Sensitivity and Specificity | 3 | 2011 | 14649 | 0.010 |
Why?
|
Capsules | 1 | 2004 | 191 | 0.010 |
Why?
|
Medicare | 1 | 2022 | 6774 | 0.010 |
Why?
|
Cytosine | 1 | 2005 | 211 | 0.010 |
Why?
|
Alcoholic Beverages | 1 | 2005 | 264 | 0.010 |
Why?
|
Guanine | 1 | 2005 | 278 | 0.010 |
Why?
|
Factor VII | 1 | 2003 | 139 | 0.010 |
Why?
|
Lod Score | 1 | 2004 | 600 | 0.010 |
Why?
|
Mental Health | 1 | 2018 | 3253 | 0.010 |
Why?
|
Leptin | 1 | 2011 | 1595 | 0.010 |
Why?
|
Confidentiality | 1 | 2007 | 608 | 0.010 |
Why?
|
Cooperative Behavior | 1 | 1990 | 1505 | 0.010 |
Why?
|
Transcription Factors | 1 | 2003 | 12116 | 0.010 |
Why?
|
Depression, Chemical | 1 | 1983 | 184 | 0.010 |
Why?
|
Apolipoproteins | 1 | 2005 | 326 | 0.010 |
Why?
|
Smoking Cessation | 1 | 2014 | 2056 | 0.010 |
Why?
|
Plasminogen Activator Inhibitor 1 | 1 | 2003 | 277 | 0.010 |
Why?
|
BCG Vaccine | 1 | 1985 | 369 | 0.010 |
Why?
|
China | 1 | 2009 | 2374 | 0.010 |
Why?
|
Cerebral Arteries | 1 | 2005 | 490 | 0.010 |
Why?
|
Adrenergic alpha-Antagonists | 1 | 1983 | 174 | 0.010 |
Why?
|
Vision Disorders | 1 | 1989 | 1088 | 0.010 |
Why?
|
Apolipoprotein C-III | 1 | 2003 | 210 | 0.010 |
Why?
|
Nervous System Diseases | 1 | 1993 | 1662 | 0.010 |
Why?
|
Program Evaluation | 1 | 2010 | 2486 | 0.010 |
Why?
|
Educational Status | 2 | 2005 | 2509 | 0.010 |
Why?
|
Sunlight | 1 | 1983 | 337 | 0.010 |
Why?
|
HIV-1 | 1 | 1999 | 6858 | 0.010 |
Why?
|
Dairy Products | 1 | 2005 | 490 | 0.010 |
Why?
|
Mice | 2 | 2020 | 81368 | 0.010 |
Why?
|
Rats, Inbred Strains | 1 | 1983 | 2088 | 0.010 |
Why?
|
Home Care Services | 1 | 1988 | 648 | 0.010 |
Why?
|
Codon | 1 | 2003 | 600 | 0.010 |
Why?
|
DNA Topoisomerases, Type I | 1 | 2001 | 106 | 0.010 |
Why?
|
Lung Diseases | 1 | 1991 | 1909 | 0.010 |
Why?
|
Complement C4 | 1 | 2001 | 216 | 0.010 |
Why?
|
Drug Interactions | 1 | 2005 | 1415 | 0.010 |
Why?
|
Environmental Exposure | 1 | 2015 | 4483 | 0.010 |
Why?
|
Seroepidemiologic Studies | 1 | 2001 | 398 | 0.010 |
Why?
|
Alzheimer Disease | 2 | 1993 | 8603 | 0.010 |
Why?
|
Complement C3 | 1 | 2001 | 434 | 0.010 |
Why?
|
DNA, Single-Stranded | 1 | 2001 | 353 | 0.010 |
Why?
|
Intracranial Hemorrhages | 1 | 2005 | 809 | 0.010 |
Why?
|
Heart Defects, Congenital | 2 | 1994 | 4671 | 0.010 |
Why?
|
Vasoconstrictor Agents | 1 | 1983 | 654 | 0.010 |
Why?
|
Adenine | 1 | 2005 | 985 | 0.010 |
Why?
|
Psychometrics | 1 | 2008 | 3062 | 0.010 |
Why?
|
Exons | 1 | 2005 | 2381 | 0.010 |
Why?
|
Tuberculosis, Pulmonary | 1 | 1985 | 831 | 0.010 |
Why?
|
Genetic Linkage | 1 | 2004 | 2340 | 0.010 |
Why?
|
Immunoglobulin G | 2 | 2001 | 4533 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2006 | 4110 | 0.010 |
Why?
|
Chronic Disease | 1 | 2012 | 9310 | 0.010 |
Why?
|
Heterozygote | 1 | 2004 | 2780 | 0.010 |
Why?
|
Catheter Ablation | 1 | 2010 | 2634 | 0.010 |
Why?
|
Urban Population | 1 | 1985 | 2034 | 0.010 |
Why?
|
Reoperation | 3 | 1993 | 4300 | 0.010 |
Why?
|
Electroencephalography | 1 | 2012 | 6240 | 0.010 |
Why?
|
Random Allocation | 1 | 2001 | 2392 | 0.010 |
Why?
|
Anxiety Disorders | 1 | 1988 | 2724 | 0.010 |
Why?
|
Quality of Life | 3 | 2012 | 13359 | 0.010 |
Why?
|
Antibody-Producing Cells | 1 | 1996 | 140 | 0.010 |
Why?
|
Immunoglobulin M | 1 | 2001 | 1526 | 0.010 |
Why?
|
Genome | 1 | 2004 | 1737 | 0.010 |
Why?
|
Respiration | 1 | 1982 | 1656 | 0.010 |
Why?
|
Behavior Therapy | 1 | 2001 | 877 | 0.010 |
Why?
|
Pediatrics | 1 | 2009 | 3589 | 0.010 |
Why?
|
Nurses | 1 | 2004 | 2477 | 0.010 |
Why?
|
Binding Sites | 1 | 1983 | 6051 | 0.010 |
Why?
|
Medical Records | 1 | 1999 | 1408 | 0.010 |
Why?
|
Ileum | 1 | 1996 | 557 | 0.010 |
Why?
|
Databases, Factual | 1 | 2009 | 7963 | 0.010 |
Why?
|
Extrapyramidal Tracts | 1 | 1993 | 17 | 0.010 |
Why?
|
Methods | 1 | 1993 | 1065 | 0.010 |
Why?
|
Rectum | 1 | 1998 | 891 | 0.010 |
Why?
|
Counseling | 1 | 2001 | 1538 | 0.010 |
Why?
|
Pulmonary Embolism | 1 | 2006 | 2568 | 0.010 |
Why?
|
HIV Infections | 1 | 1999 | 17342 | 0.010 |
Why?
|
Cranial Nerve Diseases | 1 | 1993 | 110 | 0.010 |
Why?
|
HIV Antibodies | 1 | 1999 | 1302 | 0.010 |
Why?
|
Hospital Mortality | 2 | 1997 | 5292 | 0.010 |
Why?
|
Pulmonary Wedge Pressure | 1 | 1993 | 273 | 0.010 |
Why?
|
Pupil | 1 | 1993 | 145 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2015 | 20556 | 0.010 |
Why?
|
Cardiac Surgical Procedures | 1 | 1986 | 3621 | 0.010 |
Why?
|
Adipose Tissue | 1 | 2003 | 3310 | 0.010 |
Why?
|
Sensation | 1 | 1993 | 336 | 0.010 |
Why?
|
Pyramidal Tracts | 1 | 1993 | 251 | 0.010 |
Why?
|
Reflex | 1 | 1993 | 375 | 0.010 |
Why?
|
Social Support | 1 | 2001 | 2174 | 0.010 |
Why?
|
Fontan Procedure | 1 | 1997 | 796 | 0.010 |
Why?
|
Genomics | 1 | 2006 | 5822 | 0.010 |
Why?
|
Energy Metabolism | 1 | 2001 | 2878 | 0.010 |
Why?
|
Arm | 1 | 1993 | 588 | 0.010 |
Why?
|
T-Lymphocytes | 2 | 1998 | 10175 | 0.010 |
Why?
|
Disease | 1 | 1995 | 670 | 0.010 |
Why?
|
Stress, Physiological | 1 | 1997 | 1403 | 0.010 |
Why?
|
Truth Disclosure | 1 | 1993 | 432 | 0.010 |
Why?
|
Pneumonia, Pneumocystis | 1 | 1990 | 242 | 0.000 |
Why?
|
Lymphatic System | 1 | 1990 | 253 | 0.000 |
Why?
|
Air Pollution | 1 | 1982 | 2355 | 0.000 |
Why?
|
Macaca fascicularis | 1 | 1990 | 900 | 0.000 |
Why?
|
Fluorescent Dyes | 1 | 1996 | 1901 | 0.000 |
Why?
|
Sampling Studies | 1 | 1989 | 615 | 0.000 |
Why?
|
Adjuvants, Immunologic | 1 | 1993 | 990 | 0.000 |
Why?
|
Leg | 1 | 1993 | 1087 | 0.000 |
Why?
|
Syndrome | 1 | 1994 | 3268 | 0.000 |
Why?
|
Opportunistic Infections | 1 | 1990 | 376 | 0.000 |
Why?
|
Gait | 1 | 1993 | 811 | 0.000 |
Why?
|
Comprehensive Health Care | 1 | 1988 | 123 | 0.000 |
Why?
|
Promoter Regions, Genetic | 1 | 1998 | 5780 | 0.000 |
Why?
|
Lymphocyte Activation | 1 | 1998 | 5463 | 0.000 |
Why?
|
Marriage | 1 | 1988 | 349 | 0.000 |
Why?
|
Mental Processes | 1 | 1988 | 243 | 0.000 |
Why?
|
Nuclear Proteins | 1 | 2001 | 5789 | 0.000 |
Why?
|
Mental Disorders | 1 | 1986 | 6826 | 0.000 |
Why?
|
Movement | 1 | 1993 | 1476 | 0.000 |
Why?
|
Antibodies, Viral | 1 | 1996 | 3149 | 0.000 |
Why?
|
Colombia | 1 | 1985 | 282 | 0.000 |
Why?
|
Adipose Tissue, Brown | 1 | 1990 | 762 | 0.000 |
Why?
|
Antibodies, Monoclonal | 1 | 2001 | 9171 | 0.000 |
Why?
|
Long-Term Care | 1 | 1988 | 631 | 0.000 |
Why?
|
Vascular Resistance | 1 | 1986 | 930 | 0.000 |
Why?
|
Blister | 1 | 1983 | 86 | 0.000 |
Why?
|
Central Nervous System | 1 | 1990 | 1333 | 0.000 |
Why?
|
Combined Modality Therapy | 1 | 1995 | 8516 | 0.000 |
Why?
|
B-Lymphocytes | 1 | 1996 | 4745 | 0.000 |
Why?
|
Sunburn | 1 | 1983 | 156 | 0.000 |
Why?
|
Sulfur Dioxide | 1 | 1982 | 178 | 0.000 |
Why?
|
Interviews as Topic | 1 | 1989 | 2697 | 0.000 |
Why?
|
Ohio | 1 | 1982 | 322 | 0.000 |
Why?
|
Gastrointestinal Diseases | 1 | 1990 | 1202 | 0.000 |
Why?
|
Social Class | 1 | 1990 | 1993 | 0.000 |
Why?
|
Skin Pigmentation | 1 | 1983 | 277 | 0.000 |
Why?
|
Pulmonary Veins | 1 | 1986 | 716 | 0.000 |
Why?
|
Vital Capacity | 1 | 1982 | 971 | 0.000 |
Why?
|
Pulmonary Artery | 1 | 1986 | 1927 | 0.000 |
Why?
|
Forced Expiratory Volume | 1 | 1982 | 1814 | 0.000 |
Why?
|
Kidney | 1 | 1990 | 7044 | 0.000 |
Why?
|
Postoperative Complications | 1 | 1993 | 15609 | 0.000 |
Why?
|